You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

R-FND

Showing 1 - 25 of 2,780
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Functional Neurological Disorder Trial (Psychotherapy, Physiotherapy)

Recruiting
  • Functional Neurological Disorder
  • Psychotherapy
  • +2 more
  • Pozzilli, Isernia, Italy
    I.R.C.C.S. NEUROMED Istituto Neurologico Mediterraneo
Nov 23, 2022

Functional Neurological Symptom Disorder Trial (Eye movement desensitisation and reprocessing therapy, Neuropsychiatric care)

Not yet recruiting
  • Functional Neurological Symptom Disorder
  • Eye movement desensitisation and reprocessing therapy
  • Neuropsychiatric care
  • (no location specified)
Jul 26, 2022

Functional Neurological Disorder Trial in Winnipeg (MagStim Rapid2 Transcranial Magnetic Simulation)

Not yet recruiting
  • Functional Neurological Disorder
  • MagStim Rapid2 Transcranial Magnetic Simulation
  • Winnipeg, Manitoba, Canada
    St. Boniface Hospital
Oct 1, 2021

Functional Neurological Disorder Trial in Manchester (Body Signal Integration Training)

Not yet recruiting
  • Functional Neurological Disorder
  • Body Signal Integration Training
  • Manchester, United Kingdom
    Krishna Panchmatia
Jul 3, 2023

Fascial Versus Standard Neck Dissection in N1b Papillary Thyroid

Completed
  • Patients With Papillary Thyroid Cancer and N1b Status
  • Fascial Neck Dissection
  • Standard Neck Dissection
  • Rome, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Mar 27, 2023

Functional Neurological Symptom Disorder, Paralysis, Conversion Disorder With Weakness/Paralysis Trial (Magnetic Resonance

Recruiting
  • Functional Neurological Symptom Disorder
  • +2 more
  • Magnetic Resonance Imaging (MRI)
  • Nottwil, Lucerne, Switzerland
    Swiss Paraplegic Centre
Nov 3, 2022

Bladder-sphincter Symptoms in Functional Neurological Disorders

Not yet recruiting
  • Urinary Bladder Sphincter Disorder
    • (no location specified)
    Jan 16, 2023

    Motor Functional Neurological Disorders

    Recruiting
    • Conversion Disorder
    • Standard of Care
    • Boston, Massachusetts
      Massachusetts General Hospital
    Apr 4, 2022

    Transcranial Magnetic Stimulation Tolerability inFunctional

    Recruiting
    • Functional Neurological Disorder
      • Bobigny, France
        HUPSSD
      Nov 20, 2023

      Functional Neurological Symptom Disorder Trial in London (Transcranial magnetic stimulation (TMS))

      Not yet recruiting
      • Functional Neurological Symptom Disorder
      • Transcranial magnetic stimulation (TMS)
      • London, United Kingdom
        Institute of Psychiatry, Psychology & Neuroscience
      Apr 26, 2023

      Oxytocin and Interoception in Functional Neurological Disorder

      Recruiting
      • Functional Neurological Disorder
      • Respiration resistance sensitivity task (RRST)
      • +3 more
      • Bern, Switzerland
      • +1 more
      Oct 9, 2023

      Conversion Disorder, Psychogenic Movement Disorder, Functional Movement Disorder Trial in Stanford (Embodied Virtual Reality

      Suspended
      • Conversion Disorder
      • +4 more
      • Embodied Virtual Reality Therapy
      • Virtual reality
      • Stanford, California
        Stanford University
      Nov 14, 2021

      Functional Neurological Disorder Trial (Psilocybin)

      Not yet recruiting
      • Functional Neurological Disorder
      • (no location specified)
      Feb 3, 2023

      Convulsion, Non-Epileptic Trial in Birmingham (ReACT, Supportive Therapy)

      Not yet recruiting
      • Convulsion, Non-Epileptic
      • ReACT
      • Supportive Therapy
      • Birmingham, Alabama
        University of Alabama at Birmingham
      Aug 22, 2023

      Cerebral Cavernous Malformation Trial in Italy (Propranolol)

      Completed
      • Cerebral Cavernous Malformation
      • San Giovanni Rotondo, FG, Italy
      • +5 more
      Feb 24, 2022

      Acute Myeloid Leukemia Trial in Kunming (CLL1 and CD38 dual-target CAR-T injection)

      Recruiting
      • Acute Myeloid Leukemia
      • CLL1 and CD38 dual-target CAR-T injection
      • Kunming, Yunnan, China
        920th Hospital of Joint LogisticsSupport Force of People's Liber
      Oct 26, 2023

      DLBCL Trial in Suzhou (Chidamide, Azacitidine, obinutuzumab)

      Recruiting
      • Diffuse Large B-Cell Lymphoma
      • Suzhou, Jiangsu, China
        the First Affiliated Hospital of Soochow University
      Apr 10, 2023

      PD-1 Refractory Advanced Melanoma Trial in Pittsburgh (Responder-Derived Fecal microbiota transplantation (R-FMT, Pembrolizumab,

      Not yet recruiting
      • PD-1 Refractory Advanced Melanoma
      • Responder-Derived Fecal microbiota transplantation (R-FMT
      • +2 more
      • Pittsburgh, Pennsylvania
        UPMC Hillman Cancer Center
      Sep 1, 2023

      AML, MDS Trial in Tianjin (XZB-0004)

      Not yet recruiting
      • AML
      • MDS
      • Tianjin, Tianjin, China
        Hematology Hospital, Chinese Academy of Medical Sciences
      Feb 13, 2023

      Relapsed/Refractory Large B-cell Lymphoma Trial (KITE-197, Cyclophosphamide, Fludarabine)

      Not yet recruiting
      • Relapsed/Refractory Large B-cell Lymphoma
      • (no location specified)
      Oct 6, 2023

      Radiotherapy, Breast Cancer, Relaxation Trial in Munich (Respiratory training and relaxation techniques under adjuvant radiation

      Recruiting
      • Radiotherapy
      • +3 more
      • Respiratory training and relaxation techniques under adjuvant radiation therapy in DIBH in breast cancer
      • Munich, Germany
        Department of Radiation Oncology, Technical University of Munich
      Aug 1, 2023

      Lymphoma Trial in Beijing, Shanghai City, Seoul (Obinutuzumab, Glofitamab, Rituximab)

      Recruiting
      • Lymphoma
      • Beijing, China
      • +2 more
      Oct 12, 2023

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Follicular Lymphoma Trial in Australia, China (BGB-10188,

      Recruiting
      • Chronic Lymphocytic Leukemia
      • +9 more
      • Adelaide, Australia
      • +12 more
      Jan 6, 2023

      Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphomas Trial (KT-253)

      Not yet recruiting
      • Myeloid Malignancies
      • +3 more
      • (no location specified)
      Mar 22, 2023

      Marginal Zone Lymphoma Trial (Mosunetuzumab + Lenalidomide, - Rituximab + Lenalidomide (28-days cycles, - Rituximab +

      Not yet recruiting
      • Marginal Zone Lymphoma
      • Mosunetuzumab + Lenalidomide
      • +3 more
      • (no location specified)
      Aug 16, 2023